Integrated Mapping of Skin-presenting Neglected Tropical Diseases in Liberia
NCT03683745 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56285
Last updated 2024-06-10
Summary
Appropriate targeting of interventions for neglected tropical diseases (NTDs) that require innovative and intensified disease management (IDM) requires accurate data on the distribution of these diseases within endemic countries. In most instances however, existing case register data generated through national health management information systems or during programmatic activities do not provide an accurate representation of the true burden of IDM NTDs. This study will pilot a cluster randomized screening and confirmation survey to estimate the burden of IDM NTDs characterised by skin conditions associated with long-term disfigurement and disability. These include: leprosy, Buruli ulcer, yaws and lymphoedema and hydrocele resulting from lymphatic filariasis. The survey is being conducted in one county in Liberia.
The protocol involves community-level screening by community health volunteers trained to use photo-based visual aids to recognise changes in the skin that broadly indicates patent infection. All suspected cases will be verified in their homes by local and national experts trained in the diagnosis of skin-presenting NTDs. The survey will generate accurate district-level prevalence estimates of leprosy, yaws, Buruli ulcer and lymphatic filariasis-associated lymphoedema and hydrocele and quantify the total costs and cost per case detected. In addition, results from this protocol will be compared with routinely collected case register data, to better understand how health system records reflect the true disease situation on the ground and quantify unmet need.
Conditions
- Leprosy
- Buruli Ulcer
- Yaws
- Lymphatic Filariases
Sponsors & Collaborators
-
AIM Initiative
collaborator UNKNOWN -
Ministry of Health, Liberia
collaborator OTHER -
London School of Hygiene and Tropical Medicine
lead OTHER
Principal Investigators
-
Rachel L Pullan, PhD · London School of Hygiene and Tropical Medicine
-
Karsor Kollie, MSc · Ministry of Health, Liberia
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-14
- Primary Completion
- 2018-10-30
- Completion
- 2018-12-30
Countries
- Liberia
Study Locations
More Related Trials
-
Women and Children as the Focus for Control of Schistosomiasis Infections in the Irrigations Area of Burkina Faso
NCT00463528 ·Status: COMPLETED
-
Treatment of Patients With Active Neurocysticercosis in Eastern Africa
NCT03834337 ·Status: COMPLETED
-
Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
NCT05749653 ·Status: COMPLETED ·Phase: NA
-
Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy
NCT03052998 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Burden Disease in Patients With Mast Cell Disorders
NCT04615663 ·Status: UNKNOWN
-
Schistosomiasis in Women of Reproductive Age in Burkina Faso: Implications for Control
NCT00463632 ·Status: COMPLETED
-
Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)
NCT02032043 ·Status: COMPLETED
-
Integrating Community Interventions to Eliminate Neglected Tropical Diseases
NCT03667079 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana
NCT02078024 ·Status: COMPLETED ·Phase: PHASE3
-
The Burden of (Neuro)Cysticercosis Among People Living With HIV in Rural Tanzania
NCT03851419 ·Status: COMPLETED
-
Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa
NCT01975441 ·Status: COMPLETED ·Phase: PHASE2
-
RVF and Other Emerging Infectious Diseases in East and Central Africa
NCT05139524 ·Status: RECRUITING
-
Lymphatic Filariasis (LF) in Ivory Coast
NCT02974049 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa
NCT04035174 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis
NCT03876262 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control Programmes
NCT00463593 ·Status: COMPLETED
-
Evaluation of an AI-DP for STH Deworming Programs: a Study Protocol
NCT06055530 ·Status: UNKNOWN
-
Prevalence of Intestinal Parasitic Infections in Under-Five Children With Malnutrition in Sohag, Egypt
NCT06716060 ·Status: RECRUITING
-
Buikwe Electronic Community Health Information System Impact Study
NCT06318078 ·Status: RECRUITING ·Phase: NA
-
Ivermectin Treatment of Persons With Onchocerciasis-associated Epilepsy
NCT03852303 ·Status: COMPLETED ·Phase: PHASE4
-
Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness
NCT06282315 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of Albendazole Dose on Clearance of Filarial Worms
NCT00339417 ·Status: COMPLETED ·Phase: PHASE2
-
IVM Alone vs ALB + IVM Against Onchocerciasis
NCT03238131 ·Status: COMPLETED ·Phase: PHASE3
-
Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar
NCT00713999 ·Status: COMPLETED ·Phase: NA
-
Community Directed Treatment of Soil-Transmitted Helminths Among Young Children in Zambia
NCT00349323 ·Status: COMPLETED